BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31374420)

  • 1. Structure-activity relationships of new Organotin(IV) anticancer agents and their cytotoxicity profile on HL-60, MCF-7 and HeLa human cancer cell lines.
    Ullah H; Previtali V; Mihigo HB; Twamley B; Rauf MK; Javed F; Waseem A; Baker RJ; Rozas I
    Eur J Med Chem; 2019 Nov; 181():111544. PubMed ID: 31374420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organotin(IV) complexes derived from Schiff base N'-[(1E)-(2-hydroxy-3-methoxyphenyl)methylidene]pyridine-4-carbohydrazone: synthesis, in vitro cytotoxicities and DNA/BSA interaction.
    Hong M; Geng H; Niu M; Wang F; Li D; Liu J; Yin H
    Eur J Med Chem; 2014 Oct; 86():550-61. PubMed ID: 25216377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structural characterization, and anticancer activity of a monobenzyltin compound against MCF-7 breast cancer cells.
    Fani S; Kamalidehghan B; Lo KM; Hashim NM; Chow KM; Ahmadipour F
    Drug Des Devel Ther; 2015; 9():6191-201. PubMed ID: 26648695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dibutyltin(IV) Complexes Derived from L-DOPA: Synthesis, Molecular Docking, Cytotoxic and Antifungal Activity.
    Rocha-Del Castillo E; Gómez-García O; Andrade-Pavón D; Villa-Tanaca L; Ramírez-Apan T; Nieto-Camacho A; Gómez E
    Chem Pharm Bull (Tokyo); 2018; 66(12):1104-1113. PubMed ID: 30504627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structural characterization and in vitro cytotoxicity of diorganotin (IV) diimido complexes.
    Yin H; Yue C; Hong M; Cui J; Wu Q; Zhang X
    Eur J Med Chem; 2012 Dec; 58():533-42. PubMed ID: 23164659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of complexes based on p-nitrobenzoylhydrazide, benzoylformic acid and diorganotin halides or oxides self-assemble: Cytotoxicity, the induction of apoptosis in cancer cells and DNA-binding properties.
    Jiang W; Fan S; Zhou Q; Zhang F; Kuang D; Tan Y
    Bioorg Chem; 2020 Jan; 94():103402. PubMed ID: 31718891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitumor activity of a new mixed-ligand complex di-n-butyl-(4-chlorobenzohydroxamato)tin(IV) chloride.
    Li Y; Li Y; Niu X; Jie L; Shang X; Guo J; Li Q
    J Inorg Biochem; 2008 Sep; 102(9):1731-5. PubMed ID: 18573534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonated Schiff base Sn(IV) complexes as potential anticancer agents.
    Hazra S; Paul A; Sharma G; Koch B; da Silva MFCG; Pombeiro AJL
    J Inorg Biochem; 2016 Sep; 162():83-95. PubMed ID: 27338202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
    Sirajuddin M; McKee V; Tariq M; Ali S
    Eur J Med Chem; 2018 Jan; 143():1903-1918. PubMed ID: 29133050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acetate functionalized Schiff base organotin(IV) complexes as anticancer drugs: synthesis, structural characterization, and in vitro cytotoxicity studies.
    Baul TS; Basu S; de Vos D; Linden A
    Invest New Drugs; 2009 Oct; 27(5):419-31. PubMed ID: 18941713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses, molecular structures, electrochemical behavior, theoretical study, and antitumor activities of organotin(IV) complexes containing 1-(4-chlorophenyl)-1-cyclopentanecarboxylato ligands.
    Shang X; Meng X; Alegria EC; Li Q; Guedes da Silva MF; Kuznetsov ML; Pombeiro AJ
    Inorg Chem; 2011 Sep; 50(17):8158-67. PubMed ID: 21793560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triphenyltin(IV) benzoates with diazenyl/imino scaffold exhibiting remarkable apoptosis mediated by reactive oxygen species.
    Basu Baul TS; Dutta D; Duthie A; Prasad R; Rana NK; Koch B; Tiekink ERT
    J Inorg Biochem; 2017 Aug; 173():79-92. PubMed ID: 28505480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of the interaction of novel tributyltin(IV) 2/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with an improved cytotoxic profile: synthesis, structure, biological efficacy and QSAR studies.
    Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Pellerito C; Singh P; Verma P; Duthie A; de Vos D; Verma RP; Englert U
    J Inorg Biochem; 2010 Sep; 104(9):950-66. PubMed ID: 20553814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, structural characterization and biological studies of the triphenyltin(IV) complex with 2-thiobarbituric acid.
    Balas VI; Verginadis II; Geromichalos GD; Kourkoumelis N; Male L; Hursthouse MB; Repana KH; Yiannaki E; Charalabopoulos K; Bakas T; Hadjikakou SK
    Eur J Med Chem; 2011 Jul; 46(7):2835-44. PubMed ID: 21521629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro comparative assessment with a series of new triphenyltin(IV) 2-/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with anticancer activities: structural modifications, analysis of efficacy and cytotoxicity involving human tumor cell lines.
    Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Duthie A; de Vos D; Verma RP; Englert U
    J Inorg Biochem; 2012 Feb; 107(1):119-28. PubMed ID: 22182574
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Yusof ENM; Latif MAM; Tahir MIM; Sakoff JA; Simone MI; Page AJ; Veerakumarasivam A; Tiekink ERT; Ravoof TBSA
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, cytotoxicity and DNA-binding properties of Pd(II), Cu(II) and Zn(II) complexes with 4'-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-2,2':6',2″-terpyridine.
    Chu W; Wang Y; Liu S; Yang X; Wang S; Li S; Zhou G; Qin X; Zhou C; Zhang J
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5187-91. PubMed ID: 23927970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, photophysical properties and structures of organotin-Schiff bases utilizing aromatic amino acid from the chiral pool and evaluation of the biological perspective of a triphenyltin compound.
    Basu Baul TS; Kehie P; Duthie A; Guchhait N; Raviprakash N; Mokhamatam RB; Manna SK; Armata N; Scopelliti M; Wang R; Englert U
    J Inorg Biochem; 2017 Mar; 168():76-89. PubMed ID: 28024187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-cancer activity of di- and tri-organotin(IV) compounds with D-(+)-Galacturonic acid on human tumor cells.
    Attanzio A; Ippolito M; Girasolo MA; Saiano F; Rotondo A; Rubino S; Mondello L; Capobianco ML; Sabatino P; Tesoriere L; Casella G
    J Inorg Biochem; 2018 Nov; 188():102-112. PubMed ID: 29807841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization and in vitro biological evaluation of novel organotin(IV) compounds with derivatives of 2-(5-arylidene-2,4-dioxothiazolidin-3-yl)propanoic acid.
    Pantelić NĐ; Zmejkovski BB; Božić B; Dojčinović B; Banjac NR; Wessjohann LA; Kaluđerović GN
    J Inorg Biochem; 2020 Oct; 211():111207. PubMed ID: 32801055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.